Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...
Baxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...
Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. | ...
February 20, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE ... portfolio driven by robust sales for the Novum IQ infusion pump, increased sales of parenteral nutrition products and ...
Obviously, the Novum pump has been a resounding ... So we think that that's pretty unique to Baxter and the hundreds of millions that we've invested in our platform and IV solutions due to the ...
From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and ...
ICU Medical Earnings: Benefits from Baxter Shortage Will Likely be Short-Lived for Fairly Valued ICU
Why it matters: While ICU benefitted from inflated IV solution sales in late 2024, Baxter's manufacturing facility ... businesses—including its infusion pumps growing by 7% and consumables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback